163 related articles for article (PubMed ID: 35584359)
21. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
22. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
[TBL] [Abstract][Full Text] [Related]
23. The Recent Developments of ADCs with the Tubulysins as the Payloads.
Xiangrong X; Yao L; Yao A
Mini Rev Med Chem; 2023; 23(18):1797-1805. PubMed ID: 36825713
[TBL] [Abstract][Full Text] [Related]
24. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
26. Site-Specific Antibody-Drug Conjugates in Triple Variable Domain Fab Format.
Hwang D; Rader C
Biomolecules; 2020 May; 10(5):. PubMed ID: 32422893
[TBL] [Abstract][Full Text] [Related]
27. Efficient spontaneous site-selective cysteine-mediated toxin attachment within a structural loop of antibodies.
Stadlmayr G; Stracke F; Stadlbauer K; Rybka J; Dickgiesser S; Rasche N; Becker S; Toleikis L; Rüker F; Knopp GW
Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130155. PubMed ID: 35469978
[TBL] [Abstract][Full Text] [Related]
28. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Chen H; Lin Z; Arnst KE; Miller DD; Li W
Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
[TBL] [Abstract][Full Text] [Related]
29. Agitation-Induced Aggregation of Lysine- And Interchain Cysteine-Linked Antibody-Drug Conjugates.
Johann F; Wöll S; Winzer M; Gieseler H
J Pharm Sci; 2024 May; 113(5):1265-1274. PubMed ID: 38070776
[TBL] [Abstract][Full Text] [Related]
30. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.
Li X; Patterson JT; Sarkar M; Pedzisa L; Kodadek T; Roush WR; Rader C
Bioconjug Chem; 2015 Nov; 26(11):2243-8. PubMed ID: 26161903
[TBL] [Abstract][Full Text] [Related]
31. Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.
Nanna AR; Li X; Walseng E; Pedzisa L; Goydel RS; Hymel D; Burke TR; Roush WR; Rader C
Nat Commun; 2017 Oct; 8(1):1112. PubMed ID: 29062027
[TBL] [Abstract][Full Text] [Related]
32. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
33. A new immunochemical strategy for triple-negative breast cancer therapy.
Lin CW; Zheng T; Grande G; Nanna AR; Rader C; Lerner RA
Sci Rep; 2021 Jul; 11(1):14875. PubMed ID: 34290315
[TBL] [Abstract][Full Text] [Related]
34. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
[TBL] [Abstract][Full Text] [Related]
35. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
[TBL] [Abstract][Full Text] [Related]
37. Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes.
Drake PM; Albers AE; Baker J; Banas S; Barfield RM; Bhat AS; de Hart GW; Garofalo AW; Holder P; Jones LC; Kudirka R; McFarland J; Zmolek W; Rabuka D
Bioconjug Chem; 2014 Jul; 25(7):1331-41. PubMed ID: 24924618
[TBL] [Abstract][Full Text] [Related]
38. Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability.
Sussman D; Westendorf L; Meyer DW; Leiske CI; Anderson M; Okeley NM; Alley SC; Lyon R; Sanderson RJ; Carter PJ; Benjamin DR
Protein Eng Des Sel; 2018 Feb; 31(2):47-54. PubMed ID: 29370435
[TBL] [Abstract][Full Text] [Related]
39. Conjugations to Endogenous Cysteine Residues.
Nadkarni DV
Methods Mol Biol; 2020; 2078():37-49. PubMed ID: 31643048
[TBL] [Abstract][Full Text] [Related]
40. A Simple and Efficient Method to Generate Dual Site-Specific Conjugation ADCs with Cysteine Residue and an Unnatural Amino Acid.
Zhang L; Wang Z; Wang Z; Luo F; Guan M; Xu M; Li Y; Zhang Y; Wang Z; Wang W
Bioconjug Chem; 2021 Jun; 32(6):1094-1104. PubMed ID: 34013721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
